サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1300981

植物由来APIの市場規模、シェア、動向分析レポート：分子タイプ別、最終用途別、地域別、セグメント予測：2023年～2030年

Plant-based API Market Size, Share & Trends Analysis Report By Molecule Type (Alkaloids, Anthocyanins, Flavonoids, Terpenoids), By End-use, (Pharmaceuticals, Nutraceuticals), By Region, And Segment Forecasts, 2023 - 2030

出版日
ページ情報
英文 130 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
植物由来APIの市場規模、シェア、動向分析レポート：分子タイプ別、最終用途別、地域別、セグメント予測：2023年～2030年
出版日: 2023年06月05日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

植物由来API市場の成長と動向

世界の植物由来API市場規模は2023年から2030年にかけてCAGR 6.0％で拡大し、2030年には446億5,000万米ドルに達すると予測されています。

植物由来の医薬品有効成分（API）市場の成長は、慢性疾患の有病率の上昇と、ハーブ製品に関連する高い有効性のために、薬物開発のための植物由来の製品の採用が増加していることに起因しています。例えば、タキソールはがん治療に最も効果的であり、スコポラミンは乗り物酔いに効果的であり、ブプレノルフィンは中毒治療に最適です。これらの医薬品は長い間、幅広い疾患の治療薬として使用されています。

市場成長の主な促進要因は、二次代謝産物の存在による脳機能の強化です。植物由来APIは、中枢神経系機能の修正に広く使用されています。ほとんどの植物由来の抽出物や化学物質が、精神疾患の治療においてより高い有効性を有することは、非常によく調査されています。いくつかの抽出物/植物化学物質は、様々な中枢神経系障害の治療において有望な結果をもたらすと見られています。しかし、植物化学物質の最も主要なグループには、アルカロイド、テルペン、フェノール化合物が含まれます。

アーユルヴェーダ薬や伝統的な医薬品の消費量の急増は、天然植物成分や原薬の需要の増加をもたらしています。インドには、パーソナルケア製品や医薬品の製造能力を拡大することに注力している多くの中小・大規模メーカーがあります。さらに、インドではアーユルヴェーダ医学が非常に重視されており、メーカーにとって同国のヘルスケアのニーズを満たし、開発することが重要となっています。さらに、新しい植物由来の治療薬の処方と開発のための医薬品分野の研究。例えば、2023年5月、テキサス大学サンアントニオ校とサウスウエスト研究所の研究者は、マラリアの費用対効果の高い治療法の開発に役立つ強力な抗マラリア薬であるアルテミシニンの方法を開発しました。

さらに、様々な植物由来APIの開発・製剤化に携わる主な企業は、新規治療薬を開発し、市場での競争力を維持するために、共同研究やパートナーシップに注力しています。さらに、植物由来の医薬品が提供する自然療法による植物由来医薬品への関心の高まりは、予測期間中に市場を押し上げると予想されます。さらに、医薬品需要の高まりに対応するため、多くの企業が地理的拡大や流通に関与しています。例えば、2020年4月、Brains Bioceutical Corp社は、初の承認された大麻製品のために、ブラジルにEU-GMP植物化学APIを提供するためのANVISAからの承認を発表しました。

植物由来API市場レポートハイライト

  • 分子タイプ別では、精神疾患の治療におけるアルカロイドの採用増加により、アルカロイドセグメントが2022年に最大の収益シェアを占める
  • 最終用途別では、栄養補助食品の生産に植物由来APIが多く採用されていることから、栄養補助食品分野が予測期間中に最も速い成長率を示すと予想されます。
  • 2022年は、ハーブ製品を取り入れる医学分野の研究が増加していることから、医薬品分野が市場を独占する
  • 同市場で事業を展開する主要企業は、同市場での存在感を維持するため、地理的拡大と製品の上市に絶えず注力しています。
  • 北米が2022年に最大の市場シェアを占めたが、これは規制当局の支援の高まりと植物由来医薬品への関心の高まりに起因しています。
  • 主な市場参入企業には、Roquette Freres、Arboris、Centroflora、BASF SE、Kothari Phytochemicals &Industries Ltd.、Evonik Industries AG、Brains（Brains Bioceutical）、Indo Phytochem Pharmaceuticals、HimPharm.com.、Cargill, Incorporatedなどがあります。

目次

第1章 植物由来API市場：調査手法と範囲

  • 市場セグメンテーション
  • 調査手法
  • 情報調達
  • 情報またはデータ分析
  • 市場の形成と検証
  • モデル詳細
  • 世界市場：CAGRの計算
  • 二次情報のリスト
  • 目的
  • 略語のリスト

第2章 植物由来API市場：エグゼクティブサマリー

  • 市場スナップショット
  • セグメントのスナップショット
  • 競合情勢のスナップショット

第3章 植物由来API市場：業界の展望

  • 市場系統の見通し
    • 親市場の系統の見通し
    • 関連/補助的な市場見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因
    • 市場抑制要因分析
  • SWOT分析、要因別（政治・法律、経済・技術）
  • 業界分析- ポーターの分析
  • 償還と規制のシナリオ
  • 大規模な取引と戦略的提携
    • 新製品の発売
    • 取得
    • 拡張
    • パートナーシップ
    • マーケティングとプロモーション

第4章 植物由来API市場：競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社の分類
  • ベンダー情勢
  • 公開会社
  • 非公開会社
  • 地域のネットワークマップ

第5章 植物由来API市場：分子タイプのビジネス分析

  • 定義と範囲
  • 分子タイプの市場シェア分析、2022年および2030年
  • 世界の植物由来API市場、分子タイプ別、2018年から2030年
  • 植物由来API市場：分子タイプの変動分析
  • アルカロイド
  • アントシアニン
  • フラボノイド
  • フェノール酸
  • テルペノイド
  • リグニンとスチルベン
  • その他

第6章 植物由来API市場：最終用途のビジネス分析

  • 定義と範囲
  • 最終用途の市場シェア分析、2022年および2030年
  • 世界の植物由来API市場、最終用途別、2018年から2030年
  • 植物由来API市場：最終用途の変動分析
  • 医薬品
  • 栄養補助食品
  • ハーブベースの産業

第7章 植物由来API市場：地域のビジネス分析

  • 定義と範囲
  • 地域市場シェア分析、2022年および2030年
  • 地域市場ダッシュボード
  • 地域市場のスナップショット
  • SWOT分析、要因別（政治・法律、経済・技術）
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場規模、予測、動向分析、2022年から2030年まで
  • 北米
    • 北米の植物由来API市場推計・予測、2017～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州の植物由来API市場、2018年～2030年
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋地域
    • アジア太平洋地域の植物由来API市場、2018年～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • タイ
    • オーストラリア
  • ラテンアメリカ
    • ラテンアメリカの植物由来API市場、2018年～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの植物由来API市場、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 植物由来API市場：企業概要

  • 会社の分類
  • 戦略マッピング
    • 新製品の発売
    • パートナーシップ
    • 取得
    • コラボレーション
    • 資金調達
  • 主要企業の市場シェア分析、2022年
  • 企業プロファイル
    • Roquette Freres
    • Arboris
    • Centroflora
    • Basf Se
    • Kothari Phytochemicals & Industries Ltd.
    • Evonik Industries Ag
    • Himpharm.Com.
    • Brains (Brains Bioceutical)
    • Indo Phytochem Pharmaceuticals Cargill, Incorporated.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Plant-Based API Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 5 Global Plant-Based API Market, By End Use, 2018 - 2030 (USD Million)
  • Table 6 North America Plant-Based API Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 8 North America Plant-Based API Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 11 Canada Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 12 Canada Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 13 Europe Plant-Based API Market, By Country, 2018 - 2030 (USD Million)
  • Table 14 Europe Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 15 Europe Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 16 Germany Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 17 Germany Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 18 UK Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 19 UK Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 20 France Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 21 France Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 22 Italy Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 23 Italy Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 24 Spain Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 25 Spain Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 27 Denmark Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 28 Sweden Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 29 Sweden Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 30 Norway Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 31 Norway Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Plant-Based API Market, By Country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 35 Japan Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 36 Japan Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 37 China Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 38 China Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 39 India Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 40 India Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 41 South Korea Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 42 South Korea Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 43 Australia Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 44 Australia Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45 Thailand Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 46 Thailand Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 47 Latin America Plant-Based API Market, By Country, 2018 - 2030 (USD Million)
  • Table 48 Latin America Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 49 Latin America Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 50 Brazil Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 51 Brazil Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 52 Mexico Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 53 Mexico Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 54 Argentina Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 55 Argentina Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Plant-Based API Market, By Country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 61 South Africa Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 62 South Africa Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 63 UAE Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 64 UAE Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Plant-Based API Market, By Molecule Type, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Plant-Based API Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Plant-Based API Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Plant-based API market: Molecule type outlook and key takeaways
  • Fig. 15 Plant-based API market: Molecule type movement analysis & market share 2022 & 2030
  • Fig. 16 Alkaloids plant-based API market, 2018 - 2030 (USD Million)
  • Fig. 17 Anthocyanin plant-based API market, 2018 - 2030 (USD Million)
  • Fig. 18 Flavonoids plant-based API market, 2018 - 2030 (USD Million)
  • Fig. 19 Phenolic acids plant-based API market, 2018 - 2030 (USD Million)
  • Fig. 20 Terpenoids plant-based API market, 2018 - 2030 (USD Million)
  • Fig. 21 Lignin and stilbenes plant-based API market, 2018 - 2030 (USD Million)
  • Fig. 22 Others plant-based API market, 2018 - 2030 (USD Million)
  • Fig. 23 Plant-based API market: End-use outlook and key takeaways
  • Fig. 24 Plant-based API market: End-use movement analysis & market share 2022 & 2030
  • Fig. 25 Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Nutraceuticals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Herbal based industries market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional Outlook, 2022 & 2030
  • Fig. 31 Regional Market Dashboard
  • Fig. 32 Regional Market Place: Key Takeaways
  • Fig. 33 North America, SWOT Analysis
  • Fig. 34 Europe, SWOT Analysis
  • Fig. 35 Asia Pacific, SWOT Analysis
  • Fig. 36 Latin America, SWOT Analysis
  • Fig. 37 MEA, SWOT Analysis
  • Fig. 38 North America
  • Fig. 39 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Key Country Dynamics
  • Fig. 41 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Key Country Dynamics
  • Fig. 43 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Europe
  • Fig. 45 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 46 UK Key Country Dynamics
  • Fig. 47 UK Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Germany Key Country Dynamics
  • Fig. 49 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 50 France Key Country Dynamics
  • Fig. 51 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Italy Key Country Dynamics
  • Fig. 53 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Spain Key Country Dynamics
  • Fig. 55 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark Key Country Dynamics
  • Fig. 57 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden Key Country Dynamics
  • Fig. 59 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Norway Key Country Dynamics
  • Fig. 61 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Asia Pacific
  • Fig. 63 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Japan Key Country Dynamics
  • Fig. 65 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 66 China Key Country Dynamics
  • Fig. 67 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 68 India Key Country Dynamics
  • Fig. 69 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Australia Key Country Dynamics
  • Fig. 71 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Thailand Key Country Dynamics
  • Fig. 73 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 74 South Korea Key Country Dynamics
  • Fig. 75 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Latin America
  • Fig. 77 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil Key Country Dynamics
  • Fig. 79 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Mexico Key Country Dynamics
  • Fig. 81 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Argentina Key Country Dynamics
  • Fig. 83 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 84 MEA
  • Fig. 85 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa Key Country Dynamics
  • Fig. 87 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia Key Country Dynamics
  • Fig. 89 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 90 UAE Key Country Dynamics
  • Fig. 91 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Kuwait Key Country Dynamics
  • Fig. 93 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-082-3

Plant-based API Market Growth & Trends

The global plant-based API market size is expected to reach USD 44.65 billion by 2030, expanding at a CAGR of 6.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the plant based active pharmaceutical ingredient (API) market is attributable to the rising prevalence of chronic diseases and an increasing adoption of plant based products for development of medication owing to the high effectiveness associated with herbal products. For instance, taxol is found the most effective for cancer treatment., scopolamine is found to be effective for motion sickness and buprenorphine is best adopted for addiction treatments. These drugs are long being used for medicinal purposes in treatment of wide range of diseases.

A major driver for market growth is the enhancement of brain function due to the presence of secondary metabolites. Plant based API are widely used for modification of CNS functions. It is highly researched that most plant-based extracts and chemicals have greater efficacy in treating psychiatric disorders. Several extracts/phytochemicals are seen to provide promising results in treatment of various CNS disorders. However, the most dominant group of phytochemicals include alkaloids, terpenes, and phenolic compounds.

The surge in consumption of Ayurveda drugs or traditional medicines is further giving rise to increasing demand for natural plant ingredients and API. India has many small, medium, and large-scale manufacturers that are focusing on expanding their manufacturing capabilities for personal care and medicinal products. Moreover, the ayurvedic system of medicine has highly been focused on in India which makes it important for manufacturers to develop and satisfy the need of health care in the country. Furthermore, research in field of pharmaceuticals for formulation and development of novel plant based therapeutics. For instance, in May 2023, researchers at The University of Texas at San Antonio and Southwest Research Institute developed a method for artemisinin, a potent antimalarial drug that would aid in developing cost effective treatment for malaria.

Furthermore, key players involved in developing and formulating various plant based API are focusing on collaborations and partnerships to develop novel therapeutics and to maintain their competitive position in the market. In addition, increasing interest in plant based medicines owing to natural remedies offered by them is expected to boost the market over the forecast period. Moreover, a number of players are involved in geographic expansion and distribution to meet the rising demand for medicinal products. For instance, in April 2020, Brains Bioceutical Corp announced the approval from ANVISA to provide EU-GMP Phytochemical API to Brazil, for its first approved cannabis product.

Plant-based API Market Report Highlights

  • Based on molecule type, alkaloids segment held largest revenue share in 2022 attributable to the increasing adoption of alkaloids in treatment of psychiatric disorders
  • Based on end-user, nutraceuticals segment is expected to show fastest growth rate over the forecast period owing to high adoption of plant based API in production of nutraceuticals
  • Pharmaceuticals segment dominated the market in 2022 attributable to the increasing research in field of medicine to incorporate herbal products
  • Key players operating in the market are constantly focusing on geographical expansion and product launches to maintain their presence in the market
  • North America held the largest market share in 2022 which can be attributed to the growing regulatory support and increase in interest in plant based medicine
  • A few of the key market players include Roquette Freres, Arboris, Centroflora, BASF SE, Kothari Phytochemicals & Industries Ltd., Evonik Industries AG, Brains (Brains Bioceutical), Indo Phytochem Pharmaceuticals., HimPharm.com., Cargill, Incorporated.

Table of Contents

Chapter 1 Plant-Based Api Market: Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
      • 1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
  • 1.7 Global Market: Cagr Calculation
  • 1.8 List Of Secondary Sources
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
  • 1.10 List Of Abbreviations

Chapter 2 Plant-Based Api Market: Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Plant-Based Api Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Increasing Adoption Of Plant Extract Ingredients In The Pharmaceutical And Food & Beverage Industry
      • 3.3.1.2 Rising Consumption Of Phytochemicals
      • 3.3.1.3 Extensive R&D For Development Of Novel Products For Treatment Of Various Diseases
      • 3.3.1.4 Growing Interest In Plant-Based Medicine
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Insufficient Scientific Evidence To Determine The Safety And Efficacy
      • 3.3.2.2 Quality Control-Related Issues
  • 3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4 Plant-Based Api Market: Competitive Landscape

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 4.1.1 Ansoff Matrix
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List Of Key Distributors And Channel Partners
    • 4.3.2 Key Customers
    • 4.3.3 Key Company Market Share Analysis, 2022
  • 4.4 Public Companies
    • 4.4.1 Competitive Dashboard Analysis
  • 4.5 Private Companies
    • 4.5.1 List Of Key Emerging Companies
  • 4.6 Regional Network Map

Chapter 5 Plant-Based Api Market: Molecule Type Business Analysis

  • 5.1 Definition And Scope
  • 5.2 Molecule Type Market Share Analysis, 2022 & 2030
  • 5.3 Global Plant-Based Api Market, By Molecule Type, 2018 To 2030
  • 5.4 Plant-Based Api Market: Molecule Type Movement Analysis
  • 5.5 Alkaloids
    • 5.5.1 Alkaloids Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Anthocyanins
    • 5.6.1 Anthocyanins Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7 Flavonoids
    • 5.7.1 Flavonoids Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.8 Phenolic Acids
    • 5.8.1 Phenolic Acids Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.9 Terpenoids
    • 5.9.1 Terpenoids Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.10 Lignin And Stillbenes
    • 5.10.1 Lignin And Stillbenes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.11 Others
    • 5.11.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Plant-Based Api Market: End-Use Business Analysis

  • 6.1 Definition And Scope
  • 6.2 End-Use Market Share Analysis, 2022 & 2030
  • 6.3 Global Plant-Based Api Market, By End-Use, 2018 To 2030
  • 6.4 Plant-Based Api Market: End-Use Movement Analysis
  • 6.5 Pharmaceuticals
    • 6.5.1 Pharmaceuticals Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.6 Nutraceuticals
    • 6.6.1 Nutraceuticals Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.7 Herbal-Based Industries
    • 6.7.1 Herbal-Based Industries Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Plant-Based Api Market: Regional Business Analysis

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2022 & 2030
  • 7.3 Regional Market Dashboard
  • 7.4 Regional Market Snapshot
  • 7.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 7.5.1 North America
    • 7.5.2 Europe
    • 7.5.3 Asia Pacific
    • 7.5.4 Latin America
    • 7.5.5 MEA
  • 7.6 Market Size, & Forecasts, Trend Analysis, 2022 To 2030
  • 7.7 North America
    • 7.7.1 North America Plant-Based Api Market Estimates And Forecast, 2017 - 2030 (USD Million)
    • 7.7.2 U.S.
      • 7.7.2.1 U.S. Plant-Based Api Market, 2017 - 2030 (USD Million)
      • 7.7.2.2 Key Country Dynamics
      • 7.7.2.3 Regulatory Framework
      • 7.7.2.4 Competitive Scenario
    • 7.7.3 Canada
      • 7.7.3.1 Canada Plant-Based Api Market, 2017 - 2030 (USD Million)
      • 7.7.3.2 Key Country Dynamics
      • 7.7.3.3 Regulatory Framework
      • 7.7.3.4 Competitive Scenario
  • 7.8 Europe
    • 7.8.1 Europe Plant-Based Api Market, 2018 - 2030 (USD Million)
    • 7.8.2 Uk
      • 7.8.2.1 Uk Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.8.2.2 Key Country Dynamics
      • 7.8.2.3 Regulatory Framework
      • 7.8.2.4 Competitive Scenario
    • 7.8.3 Germany
      • 7.8.3.1 Germany Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.8.3.2 Key Country Dynamics
      • 7.8.3.3 Regulatory Framework
      • 7.8.3.4 Competitive Scenario
    • 7.8.4 Spain
      • 7.8.4.1 Spain Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.8.4.2 Key Country Dynamics
      • 7.8.4.3 Regulatory Framework
      • 7.8.4.4 Competitive Scenario
    • 7.8.5 France
      • 7.8.5.1 France Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.8.5.2 Key Country Dynamics
      • 7.8.5.3 Regulatory Framework
      • 7.8.5.4 Competitive Scenario
    • 7.8.6 Italy
      • 7.8.6.1 Italy Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.8.6.2 Key Country Dynamics
      • 7.8.6.3 Regulatory Framework
      • 7.8.6.4 Competitive Scenario
    • 7.8.7 Norway
      • 7.8.7.1 Norway Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.8.7.2 Regulatory Framework
      • 7.8.7.3 Competitive Scenario
    • 7.8.8 Denmark
      • 7.8.8.1 Denmark Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.8.8.2 Key Country Dynamics
      • 7.8.8.3 Regulatory Framework
      • 7.8.8.4 Competitive Scenario
    • 7.8.9 Sweden
      • 7.8.9.1 Sweden Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.8.9.2 Key Country Dynamics
      • 7.8.9.3 Regulatory Framework
      • 7.8.9.4 Competitive Scenario
  • 7.9 Asia Pacific
    • 7.9.1 Asia Pacific Plant-Based Api Market, 2018 - 2030 (USD Million)
    • 7.9.2 Japan
      • 7.9.2.1 Japan Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.9.2.2 Key Country Dynamics
      • 7.9.2.3 Regulatory Framework
      • 7.9.2.4 Competitive Scenario
    • 7.9.3 China
      • 7.9.3.1 China Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.9.3.2 Key Country Dynamics
      • 7.9.3.3 Regulatory Framework
      • 7.9.3.4 Competitive Scenario
    • 7.9.4 India
      • 7.9.4.1 India Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.9.4.2 Key Country Dynamics
      • 7.9.4.3 Regulatory Framework
      • 7.9.4.4 Competitive Scenario
    • 7.9.5 South Korea
      • 7.9.5.1 South Korea Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.9.5.2 Key Country Dynamics
      • 7.9.5.3 Regulatory Framework
      • 7.9.5.4 Competitive Scenario
    • 7.9.6 Thailand
      • 7.9.6.1 Thailand Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.9.6.2 Key Country Dynamics
      • 7.9.6.3 Regulatory Framework
      • 7.9.6.4 Competitive Scenario
    • 7.9.7 Australia
      • 7.9.7.1 Australia Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.9.7.2 Key Country Dynamics
      • 7.9.7.3 Regulatory Framework
      • 7.9.7.4 Competitive Scenario
  • 7.10 Latin America
    • 7.10.1 Latin America Plant-Based Api Market, 2018 - 2030 (USD Million)
    • 7.10.2 Brazil
      • 7.10.2.1 Brazil Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.10.2.2 Key Country Dynamics
      • 7.10.2.3 Regulatory Framework
      • 7.10.2.4 Competitive Scenario
    • 7.10.3 Mexico
      • 7.10.3.1 Mexico Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.10.3.2 Key Country Dynamics
      • 7.10.3.3 Regulatory Framework
      • 7.10.3.4 Competitive Scenario
    • 7.10.4 Argentina
      • 7.10.4.1 Argentina Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.10.4.2 Key Country Dynamics
      • 7.10.4.3 Regulatory Framework
      • 7.10.4.4 Competitive Scenario
  • 7.11 MEA
    • 7.11.1 MEA Plant-Based Api Market, 2018 - 2030 (USD Million)
    • 7.11.2 South Africa
      • 7.11.2.1 South Africa Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.11.2.2 Key Country Dynamics
      • 7.11.2.3 Regulatory Framework
      • 7.11.2.4 Competitive Scenario
    • 7.11.3 Saudi Arabia
      • 7.11.3.1 Saudi Arabia Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.11.3.2 Key Country Dynamics
      • 7.11.3.3 Regulatory Framework
      • 7.11.3.4 Competitive Scenario
    • 7.11.4 UAE
      • 7.11.4.1 UAE Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.11.4.2 Key Country Dynamics
      • 7.11.4.3 Regulatory Framework
      • 7.11.4.4 Competitive Scenario
    • 7.11.5 Kuwait
      • 7.11.5.1 Kuwait Plant-Based Api Market, 2018 - 2030 (USD Million)
      • 7.11.5.2 Key Country Dynamics
      • 7.11.5.3 Regulatory Framework
      • 7.11.5.4 Competitive Scenario

Chapter 8 Plant-Based Api Market: Company Profiling

  • 8.1 Company Categorization
  • 8.2 Strategy Mapping
    • 8.2.1 New Product Launch
    • 8.2.2 Partnerships
    • 8.2.3 Acquisition
    • 8.2.4 Collaboration
    • 8.2.5 Funding
  • 8.3 Key Company Market Share Analysis, 2022
  • 8.4 Company Profiles
    • 8.4.1 Roquette Freres
      • 8.4.1.1 Company Overview
      • 8.4.1.2 Financial Performance
      • 8.4.1.3 Product Benchmarking
      • 8.4.1.4 Strategic Initiatives
    • 8.4.2 Arboris
      • 8.4.2.1 Company Overview
      • 8.4.2.2 Financial Performance
      • 8.4.2.3 Product Benchmarking
      • 8.4.2.4 Strategic Initiatives
    • 8.4.3 Centroflora
      • 8.4.3.1 Company Overview
      • 8.4.3.2 Financial Performance
      • 8.4.3.3 Product Benchmarking
      • 8.4.3.4 Strategic Initiatives
    • 8.4.4 Basf Se
      • 8.4.4.1 Company Overview
      • 8.4.4.2 Financial Performance
      • 8.4.4.3 Product Benchmarking
      • 8.4.4.4 Strategic Initiatives
    • 8.4.5 Kothari Phytochemicals & Industries Ltd.
      • 8.4.5.1 Company Overview
      • 8.4.5.2 Financial Performance
      • 8.4.5.3 Product Benchmarking
      • 8.4.5.4 Strategic Initiatives
    • 8.4.6 Evonik Industries Ag
      • 8.4.6.1 Company Overview
      • 8.4.6.2 Financial Performance
      • 8.4.6.3 Product Benchmarking
      • 8.4.6.4 Strategic Initiatives
    • 8.4.7 Himpharm.Com.
      • 8.4.7.1 Company Overview
      • 8.4.7.2 Financial Performance
      • 8.4.7.3 Product Benchmarking
      • 8.4.7.4 Strategic Initiatives
    • 8.4.8 Brains (Brains Bioceutical)
      • 8.4.8.1 Company Overview
      • 8.4.8.2 Financial Performance
      • 8.4.8.3 Product Benchmarking
      • 8.4.8.4 Strategic Initiatives
    • 8.4.9 Indo Phytochem Pharmaceuticals
      • 8.4.9.1 Company Overview
      • 8.4.9.2 Financial Performance
      • 8.4.9.3 Product Benchmarking
      • 8.4.9.4 Strategic Initiatives
    • 8.4.10 Cargill, Incorporated.
      • 8.4.10.1 Company Overview
      • 8.4.10.2 Financial Performance
      • 8.4.10.3 Product Benchmarking
      • 8.4.10.4 Strategic Initiatives